Oxaloacetate Supplementation for Emotional PMS
Sponsored by Terra Biological LLC
About this trial
Last updated 7 years ago
Study ID
EmotionalPMS1
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18 to 50 Years
Female
Not accepting
Healthy Volunteers
Trial Timing
Ended 8 years ago
What is this trial about?
Emotional Premenstrual Syndrome (PMS) affects millions of women worldwide. For Emotional PMS,
including depression, anxiety, perceived stress and aggression, there are very few options.
Recent observational data suggest that nutritional supplementation with oxaloacetate, a human
energy metabolite, greatly reduced the symptoms of Emotional PMS. The aim of this study was
to confirm these observations on the effects of oxaloacetate on Emotional PMS symptom
severity within a controlled clinical trial setting.
What are the participation requirements?
Inclusion Criteria
- Women with Emotional Premenstrual Syndrome (PMS),
- Women who speak English as their primary language
- Women who understand the Human Consent Form
- Ability to swallow capsules
Exclusion Criteria
- Formal diagnosis of clinical depression
- Formal diagnosis of premenstrual dysphoric disorder (PMDD).